Tingling, Burning, or Numb Feet? What Alpha-Lipoic Acid Does for Your Nerves

Nerve Health · Peripheral Neuropathy

Tingling, burning, or numb feet? The most-studied nerve-support nutrient in the world is also the most misunderstood. Here is what a peripheral nerve surgeon wants you to know before you buy a bottle.

Written by Dr. Michael Fitzmaurice, MD, peripheral nerve surgeon · Last updated: October 1, 2026

Alpha-lipoic acid (ALA) is an antioxidant your body makes in small amounts. In clinical trials in diabetic neuropathy, 600 mg a day reduced burning, tingling, and numbness over three to five weeks compared with placebo. The strongest results came from intravenous use. Oral benefit is real but modest and short-term, and longer trials are mixed.

Most people who notice their feet have started tingling assume the nerve itself is broken. In my surgical career, after performing more than 3,000 peripheral nerve procedures, I came to see it differently, and I carry that view into my consultations today. A peripheral nerve is one of the most metabolically demanding structures in the body. It is long, thin, and dependent on a fragile network of microscopic blood vessels to keep it fed and oxygenated. When those vessels and the nerve's own energy machinery start to fail, the nerve does not die quietly. It misfires. That misfiring is the burning, the prickling, the numbness, and the electric jolts that send people searching for answers at midnight.

Alpha-lipoic acid, usually shortened to ALA, sits at the center of that conversation because it acts directly on the machinery that goes wrong. It has been tested in human nerve trials for three decades, which makes it one of the few nutrients in this space with a real evidence base instead of marketing folklore. But that same evidence is routinely oversold, and the products built on it are frequently underdosed. This article walks the mechanism first, then the honest evidence, then the two questions that actually determine whether a supplement is worth your money: which form, and how much.

Alpha-lipoic acid for neuropathy: key facts

Who This Article Is For: Tingling, Burning, or Numb Feet

This article is for anyone with tingling, burning, or numb feet who is weighing alpha-lipoic acid, especially people with diabetes or prediabetes, because that is where nearly all of the trial evidence sits. Those sensations are called paresthesia (abnormal nerve signaling), and when they come from the nerves outside the brain and spinal cord, the condition is peripheral neuropathy. Diabetes is the most common cause in adults, but B12 deficiency, nerve compression, alcohol, chemotherapy, and circulation problems can all produce similar symptoms, and a nutrient that helps one cause may do nothing for another. If you are still sorting out the cause, start with my guides to burning feet causes beyond neuropathy and neuropathy vs poor circulation.

When to see a clinician first, not reach for a supplement: symptoms that come on suddenly, spread over hours or days, or climb from both feet up the legs; new weakness or trouble walking, breathing, or controlling the bladder; numbness after an injury; or a wound on a numb foot that is not healing. These can signal time-sensitive conditions. Slowly progressive tingling still deserves a conversation with your doctor to find the cause.

Why Nerves Misfire: The Hostile Environment Around a Peripheral Nerve

Peripheral nerves misfire mostly because of the environment around them, oxidative stress and reduced blood flow, rather than a defect in the nerve itself. In the most common forms of neuropathy, the damage comes from oxidative stress, an imbalance in which destructive molecules called reactive oxygen species accumulate faster than the cell can neutralize them. Think of reactive oxygen species as sparks thrown off by the cell's energy furnaces. A few are normal, but too many free radicals damage DNA, proteins, and lipids, and they begin burning the structures around the nerve.

In a metabolically stressed nerve, several things happen at once. Excess fuel floods the mitochondria, the energy plants inside each cell, and they leak more of those reactive sparks. Those sparks degrade nitric oxide, the signaling molecule that tells small blood vessels to relax and open. As nitric oxide is consumed, blood flow to the nerve drops, and a structure that was already energy-hungry is now both poisoned and starved. Layered on top of this, high glucose feeds side reactions that produce advanced glycation end-products, sticky modified proteins that gum up nerve tissue, and it switches on NF-kB, a master inflammatory switch that ramps up cytokines like TNF-alpha and IL-6. The result is a self-reinforcing cycle of oxidative damage, poor perfusion, and inflammation.

I find the surgical analogy useful. When I decompressed a chronically pinched nerve, the goal was to restore its blood supply and relieve the pressure choking it. Surgery addresses the mechanical version of this problem. But in metabolic neuropathy there is no single spot to release. Diabetic peripheral neuropathy is common, affecting up to half of people with diabetes over their lifetime, and the pressure that drives it is chemical and everywhere along the nerve. That is the gap a targeted antioxidant is designed to address, and it is the reason alpha-lipoic acid became interesting to researchers in the first place.

What Is Alpha-Lipoic Acid, and What Does It Actually Do?

Alpha-lipoic acid is a naturally occurring compound your body makes in small amounts and uses as an essential cofactor inside the mitochondria. In other words, it is not a foreign drug. It is part of the native machinery of energy production, which is part of why it is generally well tolerated. As a supplement, it is studied at far higher amounts than the body makes on its own, and at those amounts it behaves like a uniquely versatile antioxidant.

What is alpha-lipoic acid good for?

Alpha-lipoic acid is best studied for the burning, tingling, and numbness of diabetic peripheral neuropathy. More broadly, it is valued as an antioxidant that works in both the fatty and the watery parts of a cell, which most antioxidants cannot do. Vitamin C handles the watery interior of cells, vitamin E protects fatty membranes, and neither crosses easily into the other's territory. Alpha-lipoic acid, and its reduced partner molecule dihydrolipoic acid, move freely through both. That means they can reach the watery cytoplasm, the fatty membranes, and the mitochondria themselves. For a structure as long and lipid-rich as a peripheral nerve, that reach matters.

Beyond directly neutralizing reactive oxygen species, alpha-lipoic acid does three things that compound its effect. It helps regenerate the cell's own master antioxidant, glutathione, effectively refilling the tank rather than just donating a single defense, and it helps regenerate other antioxidants after they have been oxidized. It supports mitochondrial energy metabolism, since it is a built-in cofactor for the enzyme complexes that turn fuel into usable energy. And by sparing nitric oxide from oxidative destruction, it supports healthy blood flow to nerve tissue. In experimental animal models of diabetic neuropathy, this translated into measurable improvements in nerve blood flow and a reduction in oxidative markers. Those are preclinical findings, meaning they come from laboratory and animal work, and they explain the rationale rather than prove a result in people. But they line up neatly with the human mechanism, which is why the human trials were worth running.

Does Alpha-Lipoic Acid Work for Neuropathy? What the Trials Show

Yes, for short-term symptom relief in diabetic neuropathy, though the evidence weakens over time. At 600 mg a day, both intravenous and oral alpha-lipoic acid reduced burning, tingling, and numbness more than placebo over three to five weeks. Trials lasting six months or longer have not shown a clear benefit on symptoms.

These are the studies that shaped the field. Every one of them enrolled people with diabetic neuropathy, and every one used the racemic form of ALA described in the next section.

Read together, the pattern is consistent. The strongest data come from intravenous use over three weeks, where the symptom benefit is robust and replicated across more than 1,200 patients. Oral use has a real but more modest short-term signal, anchored by SYDNEY 2 and supported by the 2023 meta-analysis, which found better symptom scores but no improvement on nerve conduction or vibration testing. Over the long term the picture is mixed. NATHAN 1 missed its main goal after four years while hinting at slower progression on secondary measures, and the Cochrane review concluded that oral alpha-lipoic acid probably has little or no effect on symptoms at six months and beyond, while noting that every included study carried a high risk of bias. The 2026 network meta-analysis adds a useful nuance: intravenous ALA ranked best for quick symptom relief, while oral ALA ranked best on the lower-limb impairment score, a clinician-measured exam of the feet and legs.

On dose, the 2023 meta-analysis saw a dose-related trend in symptom scores across trials. But the only head-to-head comparison, SYDNEY 2, found no added benefit above 600 mg and more side effects at 1,200 and 1,800 mg. That is why 600 mg remains the evidence-based reference point.

I share all of this not to talk you out of the ingredient, but because a brand that hides it from you cannot be trusted on anything else. Alpha-lipoic acid is best understood as supportive, not curative.

Watch: why alpha-lipoic acid sometimes doesn't seem to work. See the video page

Does alpha-lipoic acid help non-diabetic neuropathy?

The evidence is limited. Nearly every controlled trial of alpha-lipoic acid was done in diabetic neuropathy, so those results cannot simply be transferred to neuropathy from other causes. Because the mechanism it targets, oxidative stress around the nerve, is shared by several types of neuropathy, a benefit elsewhere is biologically plausible. Plausible is not proven. If your neuropathy is not diabetic, identifying the cause comes first, and my guide to neuropathy without diabetes walks through the workup.

The Form Question: R-ALA vs Regular Alpha-Lipoic Acid

Alpha-lipoic acid, also known as thioctic acid, comes in two mirror-image versions called isomers: the R-isomer, written R-ALA, which is the form your body makes, and the S-isomer. They are built from the same atoms arranged as left and right hands of the same molecule, and which one you buy is where the quality of a product is quietly decided.

What is the difference between R-ALA and regular ALA?

R-ALA is the natural, biologically active form; regular ALA is a 50/50 mix of R and the less active S form, called racemic ALA. Most inexpensive supplements, and every major clinical trial to date, used the racemic blend. The reason the distinction matters is biological. The R-isomer is the form that fits the mitochondrial enzymes as their natural cofactor. The S-isomer is a byproduct of chemical synthesis and is far less active in those enzyme systems. In laboratory enzyme assays, the R-form reacts dramatically faster than the S-form. So when you take ordinary racemic ALA, half of what you swallow is the highly active natural form and half is a much weaker mirror image.

Which form of alpha-lipoic acid is best?

R-ALA, because it is the active form and is absorbed more efficiently, though no trial has shown better outcomes than regular ALA. That answer has two layers, and I want to give you both because the supplement industry usually gives only the flattering half. On bioavailability, R-ALA has a real and well-documented edge. In careful human pharmacokinetic studies based on oral dose comparisons, the R-isomer reaches roughly twice the peak blood concentration of the S-isomer from the same racemic dose, and its absolute absorption runs meaningfully higher. Per milligram of active compound, R-ALA delivers more of the form your mitochondria can use.

Now the part the marketing leaves out. No head-to-head clinical trial has yet shown that R-ALA produces better neuropathy outcomes than racemic ALA. Every effect size you will read about, including the ones in this article, comes from trials that used the racemic form. And in a controlled human crossover study, when researchers dosed pure R-ALA against racemic ALA but matched the actual amount of R-isomer delivered, the blood levels were equivalent. In plain terms, the R-ALA advantage is best understood as efficiency. You can reach the same active exposure with less total material and, in that study, with fewer digestive complaints. That is a genuine formulation benefit. It is not a magic upgrade, and anyone claiming R-ALA is clinically proven to outperform regular ALA for nerve outcomes is getting ahead of the data.

How much R-alpha-lipoic acid should I take for neuropathy?

No outcome trial has tested R-ALA on its own, so there is no trial-proven R-ALA dose. What we can say precisely is what the research delivered. The trials used 600 mg a day of racemic ALA, which contains about 300 mg of the R-isomer. So 300 mg of R-ALA matches the amount of R-isomer the trial participants received, and 600 mg of R-ALA delivers roughly twice that amount of the R form, at the same total milligram dose the trials used.

That is a description of what the research used, not a personal dosing instruction. The right amount for you is a conversation with your clinician, particularly if you take insulin or other glucose-lowering medication, since alpha-lipoic acid can lower blood sugar.

Dosage: How Much Alpha-Lipoic Acid Should You Take?

If there is one number to remember, it is 600 mg per day. This is not a round figure someone invented for a label. It is the dose that the pivotal human trials actually used, and there is direct head-to-head evidence for it rather than guesswork.

How much alpha-lipoic acid for nerve support?

The trials point to 600 mg once a day. In the ALADIN trial, 600 mg produced the largest symptom improvement, while a low 100 mg dose behaved barely better than placebo. In SYDNEY 2, the most important oral study, 1,200 mg and 1,800 mg improved symptoms by a similar margin to 600 mg but produced more nausea and digestive upset, and the authors concluded that 600 mg once daily offered the best balance of effectiveness and tolerability. More was not better.

So when a clinically minded nerve formula uses 600 mg, it is matching the dose the research is built on. When a bargain product gives you 100 mg or buries an unspecified amount inside a blend, it is borrowing the credibility of the 600 mg studies without delivering the 600 mg.

How long does alpha-lipoic acid take to work?

In the trials, when a benefit appeared, it began within the first one to two weeks and built over roughly three to five weeks of consistent daily use. I am deliberate about this question because false timelines are where trust gets destroyed. More research is needed to clarify which patients respond best and how durable oral effects are over time. A reasonable approach is to give it a fair trial of several weeks and reassess rather than expecting overnight change. It is not a switch, and it does not work for everyone.

When and how should you take alpha-lipoic acid?

It is usually taken once a day on an empty stomach, about 30 minutes before a meal, because food reduces how much is absorbed. A pharmacokinetic study found that taking ALA with a meal lowered blood levels of both the R and S forms compared with taking it fasting (Gleiter et al., 1996). The trade-off is that some people get stomach upset on an empty stomach. Taking it with food can ease that, but it lowers absorption, so whichever way you choose, be consistent.

Will tingling come back if you stop taking alpha-lipoic acid?

It may. The trials measured symptoms while people were taking alpha-lipoic acid, and the long-term trials do not show a lasting effect after stopping. Alpha-lipoic acid supports the environment around the nerve while you take it. It does not remove what is driving the neuropathy. The long-term course is set by the underlying cause, most often blood sugar, so that is where durable change comes from.

Safety: Side Effects and Who Should Be Cautious

At the studied dose of 600 mg a day, alpha-lipoic acid is generally well tolerated. Across the short-term trials, adverse effects at 600 mg were broadly similar to placebo. In the four-year NATHAN 1 study, people stopped treatment at similar rates on ALA and placebo, though serious adverse events were reported more often on alpha-lipoic acid (38.1% vs 28.0%); the authors still judged it well tolerated. Higher doses add side effects without adding benefit.

Side effects are typically mild, but people taking ALA can still notice stomach upset, nausea, or skin reactions, and malodorous urine has been reported with high doses of lipoic acid. People with possible thiamine (B1) deficiency, such as those with heavy alcohol use, should talk with their doctor first. Anaphylactic reactions have been reported in rare cases.

What are the side effects of alpha-lipoic acid?

The most common complaints seen with taking ALA are digestive: nausea, heartburn, or stomach upset, and an occasional skin rash. These tend to be mild and clearly dose-dependent, meaning they rise as the dose climbs, but meaningful symptom improvement does not appear to require pushing the dose higher. At 1,200 mg and above, nausea and vomiting became noticeably more frequent in the trials, which is part of why 600 mg is the sweet spot. Taking it with food can ease stomach upset, but it also lowers absorption, so it is a trade-off.

Who should avoid it, and what should you not mix it with?

People taking insulin or other glucose-lowering drugs, thyroid medication, or chemotherapy, and anyone pregnant or breastfeeding, should check with their clinician before taking alpha-lipoic acid. Because it can enhance insulin sensitivity, it may lower blood sugar, so anyone on glucose-lowering medication should monitor closely to avoid hypoglycemia. There are reports of interaction with thyroid medication, so people on thyroid hormone replacement should raise it with their prescriber. People undergoing chemotherapy should not add antioxidants without their oncology team's sign-off, since high-dose antioxidants can theoretically interact with certain treatments. And there is not enough safety data to recommend it during pregnancy or breastfeeding. None of this makes alpha-lipoic acid dangerous for the general adult. It makes it a real compound with real effects, which is exactly why it deserves respect rather than casual stacking.

Alpha-Lipoic Acid With B12 and Benfotiamine: Why Combine Them?

Yes, you can take B12 and alpha-lipoic acid together. There is no known interaction between them, and they act on different pathways: alpha-lipoic acid on oxidative stress and mitochondrial energy, methylcobalamin on myelin and nerve repair. Most of the combination data are short-term or intravenous, so the case rests more on mechanism than on long-term outcome trials.

Alpha-lipoic acid targets oxidative stress and mitochondrial energy. It does not directly repair the insulation around nerves, and it does not address the metabolic damage pathway driven by high blood sugar and insulin resistance. Two other nutrients map onto exactly those gaps. Methylcobalamin, the active coenzyme form of vitamin B12, is the form involved in maintaining myelin, the insulating sheath, and in supporting nerve repair processes; it is a more bioactive form than the cheap cyanocobalamin found in most multivitamins. Benfotiamine, a fat-soluble and far better-absorbed form of vitamin B1, helps reroute the toxic glucose byproducts that damage nerves in the first place. Three nutrients, three different layers of the same problem.

The mechanistic logic for combining them is strong, and there is supportive clinical signal that pairing alpha-lipoic acid with methylcobalamin outperforms methylcobalamin alone on nerve conduction measures, though much of that combination data is short-term and intravenous rather than from oral supplements, so I hold it loosely. What I will say firmly is the design principle: if you are going to support nerves nutritionally, it makes more sense to cover the oxidative, the regenerative, and the metabolic angles together than to throw a single under-dosed ingredient at a multi-layered problem.

This is the principle behind NeuroAxis, the nerve support supplement I formulated: address the oxidative, regenerative, and metabolic layers together rather than relying on one under-dosed ingredient. It is designed to support healthy nerve function, and to be honest about what that means.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

What to Do, and in What Order

Frequently Asked Questions

Is alpha-lipoic acid good for nerve pain?

It is one of the most-studied nutrients for neuropathic pain, with the best short-term evidence at 600 mg per day. In diabetic neuropathy, it may help reduce symptoms over the short term. It supports the antioxidant and energy systems a stressed nerve relies on. It is best viewed as supportive of healthy nerve function rather than as a treatment that cures nerve damage, and longer-term data are mixed.

Does alpha-lipoic acid help neuropathy in the feet?

That is largely where it was studied. Diabetic neuropathy starts in the feet, and the trial symptom scores for burning, prickling, numbness, and stabbing pain were measured in the feet. At 600 mg a day, those scores improved more than with placebo over three to five weeks. It supports symptom relief rather than reversing nerve damage, and it works best alongside addressing the cause, such as blood sugar.

What is the best form of alpha-lipoic acid?

R-alpha lipoic acid, often stabilized as a salt for shelf life, is the biologically active isomer and is absorbed more efficiently per milligram than the racemic blend found in most cheap products. No trial has yet proven it produces superior nerve outcomes, but it is the more rational choice for delivering the active form.

How much alpha-lipoic acid should I take per day for nerves?

The clinical trials center on 600 mg per day. Many alpha lipoic acid supplements provide far less than that studied amount, so compare the labeled daily dose rather than assuming every product matches the research. Head-to-head data show no added benefit above that dose and more digestive side effects, so 600 mg is widely regarded as the optimal balance of effectiveness and tolerability. Always confirm with your own clinician, especially if you take other medication.

How much R-alpha-lipoic acid should I take for neuropathy?

No trial has tested R-ALA on its own. The neuropathy trials used 600 mg a day of racemic ALA, which contains about 300 mg of R-ALA. So 300 mg of R-ALA matches the R-isomer amount the trials delivered, and 600 mg of R-ALA delivers roughly twice that. Treat these as what the research used rather than a personal dose, and confirm with your clinician.

How long does alpha-lipoic acid take to work?

In the trials, symptom changes tended to begin within one to two weeks and build over three to five weeks of daily use. Treat it as a multi-week trial and reassess, rather than expecting an immediate effect. More research is still needed to clarify who responds best to oral use over longer periods. It does not help everyone.

Will nerve symptoms come back if I stop taking alpha-lipoic acid?

They may. The trials measured symptoms while people were taking alpha-lipoic acid, and none has shown a lasting benefit after stopping. It supports the environment around the nerve while you take it but does not remove what is driving the neuropathy. The long-term course depends on the underlying cause, most often blood sugar, so addressing that is what produces durable change.

Can you take alpha-lipoic acid with B12?

Yes, and there is a mechanistic and supportive clinical rationale for pairing them. Alpha-lipoic acid targets oxidative stress, while the active B12 form methylcobalamin supports the nerve's insulation and repair processes. The two address different layers of nerve health, which is why thoughtful formulas combine them, often with benfotiamine as well.

Is there such a thing as alpha-lipoic acid deficiency?

There is no recognized dietary alpha-lipoic acid deficiency, because your body makes the small amount it needs. The symptoms people search for, such as tingling, burning, or numb feet, are usually the neuropathy itself, not a missing supplement. That makes them a reason to investigate the cause, such as blood sugar, B12 status, or nerve compression, rather than a sign you are low in alpha-lipoic acid.

Who should not take alpha-lipoic acid?

Use caution and consult your physician if you take insulin or other blood-sugar-lowering medication, take thyroid hormone, are undergoing chemotherapy, or are pregnant or breastfeeding. Alpha-lipoic acid is also found in small amounts in foods such as spinach, broccoli, potatoes, and yams, with richer animal sources in red meat and organ meats like liver, though those food amounts are far below supplement doses. For most other adults it is generally well tolerated at 600 mg per day.

This content is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Individual results vary. Always consult a qualified healthcare provider regarding your individual medical situation.